LD-2 disclosure · 2nd Quarter - Report
ALKERMES, INC.
Income$60Kfee reported
Client
- Name
- ALKERMES, INC.
- Description
- biopharmaceutical company
- Location
- Massachusetts · United States of America
Registrant
- Description
- lobbying firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issuePharmacy
Policiesimpacting pharmaceutical development, patient access, drug pricing, and supply chain.
LobbyistsMATHEW LAPINSKI · JASON BENJAMIN VAN PELT · ms CHERYL LYNN JAEGER · mr STEPHEN THOMAS VOLJAVEC
TargetedSENATE · HOUSE OF REPRESENTATIVES